/ Unichem Lab for Ghaziabad plant receives EIR from USFDA ~ Ways2Capital|Stock Tips|Stock Market Tips|Intraday Stock Tips|Stock Trading Tips|NSE BSE Tips

Wednesday, 7 June 2017

Leading pharma company, Unichem Laboratories Limited has said that the company's formulations manufacturing facility in Ghaziabad have received an Establishment Inspection Report (EIR) from the USFDA. the successful closure of the inspection and the queries raised during the audit, this receipt indicates.

USFDA closed the inspection.The inspection was carried out between 24th Feb 2017 to 3rd March 2017,” the company said in a filing to the Bombay Stock Exchange.
Gastroenterology, cardiology, Diabetology, psychiatry, neurology, anti-bacterial, anti-infectives and pain management, this area of Unichem pharma products are addressing the needs of relevant and growing therapeutic areas. Besides, the share of the company was trading at Rs. 251.65 apiece, up 1.94% from the previous close on BSE.  

For Quick Trial – 8962000225 ✔ 
or mail us here: info@ways2capital.com
or visit http://www.ways2capital.com
✆ - 0731-6626222 | Toll Free - 1800-3010-2007 ✔ 
Give a Missed Call for Free Trial - 09699997717 ✔